SAN JOSE, Calif.--(BUSINESS WIRE)--HTS laboratories continue to adopt new technologies and practices that are leading to more effective drug discovery approaches. For example, the directors at HTS laboratories see an increase in the importance of phenotypic screens. In addition, there is a greater use of high content assays, and a greater emphasis on understanding the biologic relevance of targets screened at HTS laboratories. These trends have resulted in HTS laboratories screening fewer targets now than in the past, but with better results. The HTS directors report a greater proportion of their targets generating new drug leads.
